● TALENT ONE MARKET INTELLIGENCE: GENESIS THERAPEUTICS
🔥 TALENT LIQUIDITY:
Extremely tight. The intersection of high-level engineering and GTM strategy in stealth biotech is a 1:30 supply-to-demand ratio.
📈 ALPHA SIGNAL:
This role provides equity in a high-velocity firm that is likely to exit or IPO once the stealth phase ends, effectively guaranteeing a massive liquidity event that covers your mortgage for the next decade.
EST. COMPENSATION
$240k – $300k Base + Significant Equity Upside
$240k – $300k Base + Significant Equity Upside
SECTOR HEAT
88.0/100
88.0/100
CANDIDATE PROTOCOL: Focus on your ability to bridge the gap between high-throughput computational biology and commercialization. Emphasize your track record of ‘stealth’ execution.
Official Role Description: Genesis Therapeutics
Genesis Therapeutics is experiencing high capital velocity but suppressing public headcount. We are hunting stealth mandates in Engineering and GTM.
